Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05913713 · ClinicalTrials.gov registry record · NA
HIIT Following Breast Cancer Chemotherapy
A NA study of Breast Cancer, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 158
- Enrollment target
- 1
- Study location
NCT05913713: Recruiting NA study of Breast Cancer, sponsored by University of Florida.
NCT05913713 is a NA study of Breast Cancer that is actively recruiting participants, run by University of Florida. The registered enrollment target is 158 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05913713, a NA study of Breast Cancer, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
- 1
- Study location
Study Summary
Chemotherapy is an effective breast cancer treatment, which helped to increase the 5-year survival rate to approximately 95%. However, breast cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabilitation can be an effective strategy to decrease the incidence of CVD and its risk factors in this population. The proposed study may help to examine the effect and durability of a novel high-intensity interval training compared to moderate-intensity continuous training on cardiovascular rehabilitation in breast cancer survivors.
Primary Outcome
Flow-mediated dilation (FMD) is an established non-invasive measure of endothelial function. Brachial artery FMD will be determined via ultrasonography in response to reactive hyperemia following 5-min forearm ischemia.
Conditions Studied
Interventions
- BEHAVIORAL 12-week Intervention Period
- BEHAVIORAL 12-week Observation Period
Study Locations (1)
Florida
- Integrative Cardiovascular Physiology Laboratory, University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2024-03-07 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT05913713 shows while recruiting
NCT05913713 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which 12-week Intervention Period is the first listed.
NCT05913713 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05913713 about?
NCT05913713 is a clinical study titled "HIIT Following Breast Cancer Chemotherapy". Chemotherapy is an effective breast cancer treatment, which helped to increase the 5-year survival rate to approximately 95%. However, breast cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabilitation can be an ef...
What is the current status of trial NCT05913713?
This trial is currently recruiting. It is a NA study. The enrollment target is 158 participants. The study started on 2024-03-07. Estimated completion is 2026-05-31.
What conditions does trial NCT05913713 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT05913713?
The interventions under investigation include: 12-week Intervention Period (BEHAVIORAL), 12-week Observation Period (BEHAVIORAL).
Who is sponsoring clinical trial NCT05913713?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05913713 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05913713's enrollment target sits among peer trials
158 436th of 1224 higher than 788 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
- NCT05789329 · 158 participants · NA
Non-Inferiority Trial of TrIGR for PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI